Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
Fixed Capital/Sales

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 0.960.950.640.600.40

What is the latest Fixed Capital/Sales ratio of GLAND PHARMA ?

The latest Fixed Capital/Sales ratio of GLAND PHARMA is 0.96 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20260.96
Mar20250.95
Mar20240.64
Mar20230.60
Mar20220.40

How is Fixed Capital/Sales of GLAND PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2026 0.96
1.05
Mar2025 0.95
48.44
Mar2024 0.64
6.67
Mar2023 0.6
50.00
Mar2022 0.4 -

Other Financial Ratios of GLAND PHARMA


Compare Fixed Capital/Sales ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹47,527.4 Cr -2.7% -3% 52.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,278.0 Cr -2.5% -4.7% 15.5% Stock Analytics
DIVIS LABORATORIES ₹243,966.0 Cr -4% 8.1% 55.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,478.0 Cr -2.3% 0.2% 36.6% Stock Analytics
CIPLA ₹109,950.0 Cr -1.7% -6.1% -12% Stock Analytics
DR REDDYS LABORATORIES ₹95,967.4 Cr -0.2% -4.4% -10.2% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2.7%

-3%

52.3%

SENSEX

-2.8%

-5.2%

-8.4%


You may also like the below Video Courses